496 related articles for article (PubMed ID: 15801245)
1. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
Schenkel E; Corren J; Murray JJ
Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
Anolik R
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):683-94. PubMed ID: 19473112
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
9. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
[TBL] [Abstract][Full Text] [Related]
10. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
11. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
16. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
Salmun LM; Lorber R
BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
[TBL] [Abstract][Full Text] [Related]
17. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
18. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
Keith PK; Luciuk G
Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
